Page 9 - Tissue Technologies News Today

Teza Capital Management LLC grew its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) by 9.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,114 shares of the life sciences company’s stock after acquiring an […]

26.10.2022 - PRINCETON, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) - Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2022. Third ...

PRINCETON, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced the appointment of Harvinder...

27.07.2022 - PRINCETON, N.J., July 27, 2022 (GLOBE NEWSWIRE) - Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2022. Second Quarter ...

Integra will sell its traditional wound care business to Gentell for up to $28.8 million. The expected close is around the end of August.

IART earnings call for the period ending September 30, 2021.

Integra Lifesciences Holdings Corp (IART) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Integra Lifesciences Holdings Corp (NASDAQ: IART) Popular Searches Operator Ladies and gentlemen, good day, and welcome to the Integra LifeSciences First Quarter 2021 Financial Results Call. At this time, I would like to turn the conference over to Mr. Mike Beaulieu, Head of Investor Relations. Please go ahead, sir.SPON...

Integra Lifesciences Holdings Corp (IART) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Integra Lifesciences Holdings Corp (NASDAQ: IART) Popular Searches Operator Good day and welcome to the Integra LifeSciences Fourth Quarter and Full Year 2020 Financial Results Call. Todays conference is being recorded, and at this time, I would like to turn the conference over to Michael Beaulieu, Director Investor Rel...